efficacy of ursodeoxycholic plus phototherapy in the treatment of neonatal jaundice

Phase 4

• Conditions: eonatal jaundice.; Neonatal jaundice due to other excessive haemolysis, Neonatal jaundice from other and unspecified causes; P58, P59

• Registration Number: IRCT201611163127N3
• Lead Sponsor: Vice chancellor for research, Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Birth weight between 2500 to 4000 g; Only breastfeeding; Gestational age between 38 to 41 weeks; Older than 3 days, total bilirubin between 14 to 20 mg/dL; direct bilirubin less than 2 mg/dL.
Exclusion criteria: ABO and RH incompatibility; G6PD Deficiency; Direct hyperbilirubinemia; Septicemia; diseases leading to hyperbilirubinemia (including Crigler-Najjar syndrome, Gilbert's syndrome, hypothyroidism / hyperthyroidism, liver diseases, and ....); Premature infants; Newborns of diabetic mothers.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total bilirubin. Timepoint: on admission and every 12 hours after admission until discharge. Method of measurement: Blood sampling.;Time duration in which bilirubin levels reaches to normal level. Timepoint: Continuously (from treatment beginning until bilirubin reach to normal levels). Method of measurement: Timer.

Secondary Outcome Measures

Name	Time	Method
-. Timepoint: -. Method of measurement: -.